Antoine-Guy L.
- Country
- France
- Department
- Endocrinologie, Diabétologie et Maladies métaboliques
Research Overview
Data & Insights
Has run more than one trial at 1 of 23 partner sites.
Specializations
Cardiometabolic and Vascular Disease
Antoine-Guy LOPEZ is involved in clinical research on atrial fibrillation, heart failure, atherosclerotic cardiovascular disease, stroke prevention, and venous thromboembolism. His research landscape also includes hypertension, pulmonary hypertension, and cardiovascular risk reduction.
- Atrial fibrillation
- Heart failure
- Stroke prevention
- Venous thromboembolism
- Pulmonary hypertension
His work reflects a strong therapeutic interest in preventing major cardiovascular events and improving long-term vascular outcomes.
Autoimmune and Inflammatory Disorders
He is actively engaged in studies of rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, ANCA-associated vasculitis, giant cell arteritis, and systemic sclerosis. Additional interests include lupus, inflammatory myopathies, and Behçet-related vascular disease.
- Rheumatoid arthritis
- ANCA-associated vasculitis
- Systemic sclerosis
- Psoriatic arthritis
- Giant cell arteritis
His therapeutic focus extends to immune-mediated disease control, with attention to both systemic inflammation and organ-threatening complications.
Renal and Transplant Medicine
His clinical trial activity includes chronic kidney disease, end-stage renal disease, kidney transplantation, renal allograft rejection prevention, and atypical hemolytic uremic syndrome. He also works in areas linked to proteinuria, kidney failure, and transplant-related infection risk.
- Chronic kidney disease
- Kidney transplantation
- Renal allograft rejection
- Atypical hemolytic uremic syndrome
- End-stage renal disease
This area of interest highlights therapeutic work in renal protection, transplant maintenance, and immune-mediated kidney injury.
Respiratory and Pulmonary Inflammation
He is involved in research on asthma, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, progressive pulmonary fibrosis, pulmonary arterial hypertension, and chronic pulmonary aspergillosis. His portfolio also includes interstitial lung disease and sarcoidosis.
- Asthma
- Idiopathic pulmonary fibrosis
- Pulmonary arterial hypertension
- Chronic pulmonary aspergillosis
- Interstitial lung disease
His therapeutic activity centers on chronic respiratory disease control and the management of inflammatory and fibrotic lung disorders.
Metabolic, Hepatic, and Gastrointestinal Disease
Antoine-Guy LOPEZ also contributes to trials in obesity, non-alcoholic steatohepatitis, alcohol-related liver disease, gout, Crohn’s disease, and irritable bowel syndrome. His interests extend to hepatitis B, hepatocellular carcinoma, and pancreatic and gastrointestinal malignancies.
- Obesity
- Non-alcoholic steatohepatitis
- Gout
- Crohn’s disease
- Irritable bowel syndrome
His research activity spans metabolic regulation, liver disease management, and inflammatory gastrointestinal conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.